Delayed onset of malignant hyperthermia without creatine kinase elevation in a geriatric, ryanodine receptor type 1 gene compound heterozygous patient

Anesthesiology

Volumn 107, Issue 2, 2007, Pages 350-353

  Newmark, Jordan L ^a   Voelkel, Maria ^b   Brandom, Barbara W ^d,e   Wu, John ^c  

^a TEMPLE UNIVERSITY   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CREATINE KINASE; DANTROLENE; DILTIAZEM; EPHEDRINE; ERYTHROMYCIN; FAMOTIDINE; FENTANYL; HYDROMORPHONE; ISOFLURANE; LISINOPRIL; METOPROLOL; METRONIDAZOLE; MIDAZOLAM; NEOMYCIN; PROPOFOL; ROCURONIUM; RYANODINE RECEPTOR 1; WARFARIN;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BISPECTRAL INDEX; BLOOD PRESSURE CUFF; BREATHING RATE; CAPNOGRAPHY; CASE REPORT; CREATINE KINASE BLOOD LEVEL; ELECTROCARDIOGRAM; ENDOTRACHEAL INTUBATION; FEVER; GENE MUTATION; GENERAL ANESTHESIA; GENETIC ANALYSIS; HEART RATE; HETEROZYGOTE; HUMAN; HYPOTENSION; INFLUENZA VACCINATION; MALE; MALIGNANT HYPERTHERMIA; MUSCLE SPASM; NERVE STIMULATION; PRIORITY JOURNAL; PULSE OXIMETER; SARCOPLASMIC RETICULUM; SEDATION; TOTAL HIP PROSTHESIS; VITAL SIGN;

AGED; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COLOSTOMY; CREATINE KINASE; DANTROLENE; GASTROESOPHAGEAL REFLUX; GENETIC PREDISPOSITION TO DISEASE; HEART RATE; HETEROZYGOTE; HUMANS; HYPERTENSION; ISOFLURANE; MALE; MALIGNANT HYPERTHERMIA; METOPROLOL; MONITORING, INTRAOPERATIVE; MUSCLE RELAXANTS, CENTRAL; OSTEOARTHRITIS; PULMONARY EMBOLISM; RECTAL NEOPLASMS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TIME FACTORS; VENOUS THROMBOSIS;

EID: 34547570808     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000271866.37280.85     Document Type: Article

References (26)

1. Gronert GA, Antognini JF, Pessah IN: Malignant hyperthermia, Anesthesia 5th edition. Edited by Miller RD. Philadelphia, Churchill Livingstone, 2000, pp 1033-52
2. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, Kaplan RF, Muldoon SM, Nelson TE, Ording H, Rosenberg H, Waud BE, Wedel DJ: A clinical grading scale to predict malignant hyperthermia susceptibility. ANESTHESIOLOGY 1994; 80:771-9
3. Sei Y, Sambuughin NN, Davis EJ, Sachs D, Cuenca PB, Brandom BW, Tautz T, Rosenberg H, Nelson TE, Muldoon SM: Malignant hyperthermia in North America: Genetic screening of the three hot spots in the type 1 ryanodine receptor gene. ANESTHESIOLOGY 2004; 101:824-30
4. Gillard EF, Otsu K, Fujii J, Khanna VK, De Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH: A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991; 11:751-5
5. 2+ release channel of skeletal sarcoplasmic reticulum is responsible for hypersensitivity to caffeine and halothane in malignant hyperthermia. J Biol Chem 1994; 269:9413-5
6. Keating KE, Quane KA, Manning BM, Lehane M, Hartung E, Censier K, Urwyler A, Klausnitzer M, Muller CR, Heffron JJA, McCarthy TV: Detection of a novel RYR1 mutation in four malignant hyperthermia pedigrees. Hum Mol Genet 1994; 3:1855-8
7. Phillips MS, Khanna VK, De Leon S, Frodis W, Britt BA, MacLennan DH: The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia. Hum Mol Genet 1994; 3:2181-6
8. Brandt A, Schleithoff L, Jurkat-Rott K, Klingler W, Baur C, Lehmann-Horn F: Screening of the ryanodine receptor gene in 105 malignant hyperthermia families: Novel mutations and concordance with the in vitro contracture test. Hum Mol Genet 1999; 8:2055-62
9. Urwyler A, Deufel T, McCarthy T, West S, European Malignant Hyperthermia Group: Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 2001; 86:283-7
10. Nelson TE, Rosenberg H, Muldoon SM: Genetic testing for malignant hyperthermia in North America. ANESTHESIOLOGY 2004; 100:212-4
11. Girard T, Treves S, Voronkov E, Siegemund M, Urwyler A: Molecular genetic testing for malignant hyperthermia susceptibility. ANESTHESIOLOGY 2004; 100:1076-80
12. Monnier N, Krivosic-Horber R, Payen JF, Kozak-Ribbens G, Nivoche Y, Adnet P, Reyford H, Lunardi J: Presence of two different genetic traits in malignant hyperthermia families. ANESTHESIOLOGY 2002; 97:1067-74
13. Robinson RL, Brooks C, Brown SL, Ellis FR, Halsall PJ, Quinnell RJ, Shaw M-A, Hopkins PM: RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes. Hum Mutat 2002; 20:88-97
14. 2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease. J Biol Chem 1997; 272:26332-9
15. McKinney LC, Butler T, Mullen SP, Klein MG: Characterization of ryanodine receptor-mediated calcium release in human B cells. ANESTHESIOLOGY 2006; 104:1191-201
16. Karan SM, Crowl F, Muldoon SM: Malignant hyperthermia masked by capnographic monitoring. Anesth Analg 1994; 78:590-2
17. Antognini JF: Creatine kinase alterations after acute malignant hyperthermia episodes and common surgical procedures. Anesth Analg 1995; 81:1039-42
18. Yoganathan T, Casthely PA, Lamprou M: Dantrolene induced hyperkalemia in a patient treated with diltiazem and metoprolol. J Cardiothorac Anesth 1988; 2:363-4
19. 2+ release. J Cell Biol 2006; 174:639-45
20. Melzer W: When sparks get old. J Cell Biol 2006; 174:613-4
21. Gronert GA, Milde JH: Variations in onset of porcine malignant hyperthermia. Anesth Analg 1981; 60:499-503
22. Gillmeister I, Schummer C, Hommann M, Schummer W: Delayed onset of malignant hyperthermia crisis during a living donor liver transplantation caused by sevoflurane [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39:153-6
23. Hoenemann CW: Delayed onset of malignant hyperthermia in desflurane anesthesia. Anesth Analg 2003; 96:165-7
24. Papadimos TJ, Almasri M, Padgett JC, Rush JE: A suspected case of delayed onset malignant hyperthermia with desflurane anesthesia. Anesth Analg 2004; 98:548-9
25. Uskova AA, Matusic BP, Brandom BW: Desflurane, malignant hyperthermia, and release of compartment syndrome. Anesth Analg 2005; 100:1357-60
26. Moseley PL: Heat shock proteins and heat adaptation of the whole organism. J Appl Physiol 1997; 83:1413-17